European Investment Bank (EIB) plans to terminate Volkswagen from research funding citing the infamous Dieselgate scandal
Category: #world  By Pankaj Singh  Date: 2017-08-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

European Investment Bank (EIB) plans to terminate Volkswagen from research funding citing the infamous Dieselgate scandal

The European Investment Bank (EIB) has apparently decided to cut off Volkswagen from any type of funding for research activities owing to the alleged emissions cheating scandal. This move is likely to prove disastrous for Volkswagen, considering its present vulnerable market situation.

For the record, EIB is EU’s long-term non-profit institution that provides sound investments to organizations with an aim to transform the economy of the continent. EIB, in 2009, had granted a loan of EUR 400 million to VW for developing advanced technology, which it suspects, were used to develop technology for cheating in the emission tests. Reports claim that since 1990, Volkswagen has received about EUR 5 billion from the EIB, out of which, more than 30% was invested in the development of eco-friendly cars. Based on the investigation undertaken by EU’s antifraud wing OLAF on VW’s strategy regarding the development of fuel efficient & pollutant free diesel engine as well as expenditure structure of the 400 million euros since November 2015, EIB has levied fraud charges against the company.

EU’s antifraud agency has been in touch with the German authorities to effectuate the necessary action against company’s officials, as OLAF has an authorization to solely investigate, and not to prosecute the fraudsters within the EU companies. Reports claim that German prosecutors have been making several investigations on VW’s former top executives charged with the case of fraud.

Volkswagen has admitted that their vehicles were indeed emitting harmful nitrogen oxides, but in September 2015, the company installed software devices in 11 million diesel engine cars across the globe to reduce the emission of harmful gases. Subject to the allegation filed by the EIB, VW denied any wrongdoing with the loan received from the EIB, and has claimed that it used all the funds for the designated purpose. In defense, VW also added that it has been investing some resources into the development of automated electric vehicles.

The President of the European Investment Bank Werner Hoyer has stated that the bank has been verifying the investigation profiled by OLAF regarding the Dieselgate scandal. He has also stated that in the light of recent events, the EIB has scrapped all the business tie-ups with Volkswagen and bank won’t consider any loan proposal from this automaker until the end of the investigation. Though this decision is temporary, the research contribution of VW in the automotive market is likely to suffer a major hit pertaining to shortage of funds. In addition, the reputation of the company has gone down the drain, in the wake of the ongoing electric vehicle project. It now remains to be seen what the investigation results bring forth for Volkswagen and whether they will help the company regain its business position.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Flipkart launches Loyalty Program across 5,000 retail outlets in India
Flipkart launches Loyalty Program across 5,000 retail outlets in India
By Pankaj Singh

E-commerce giant Flipkart has recently launched SuperCoin Pay, a system of currency which its customers will have the right to use across tons of retail stores in the country. Flipkart is betting on its loyalty program...

Sirnaomics reveals dose administration of 1st patient in STP705 trial
Sirnaomics reveals dose administration of 1st patient in STP705 trial
By Pankaj Singh

Sirnaomics, Inc., a clinical-stage biopharmaceutical company, has recently announced the dose administration of the 1st patient in a Phase 2a clinical trial of STP705. STP705 is a lead drug candidate develop...

Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
By Pankaj Singh

The pharma giant Pfizer Inc. has reportedly declared that the U.S. Food and Drug Administration (US FDA) has approved the sNDA (supplemental New Drug Application) for XALKORI® (crizotinib) for the treatment of chil...